Statistics & Data Corporation (SDC), a pioneer in clinical trial biometrics, has unveiled its groundbreaking Bring Your Own Device (BYOD) electronic Patient Reported Outcomes (ePRO) solution. This innovation marks a paradigm shift in clinical research, eliminating the reliance on paper-based data collection.
SDC Capture BYOD is a cost-effective platform that empowers participants to submit clinical trial information using their personal devices. This approach enhances flexibility, reduces patient burden, and improves data quality.
Dr. Richard Abelson, CEO of SDC, indicated that SDC Capture BYOD is a pivotal step in our commitment to optimizing clinical research by eliminating paper, enriching participant experience, and maximizing trial efficiency.
Key benefits include:
• Elimination of paper from trial processes, increasing efficiency and reducing costs.
• Increased participant recruitment and adherence due to enhanced convenience and reduced burden.
• Improved data quality and endpoint realization, resulting in more accurate and reliable clinical outcomes.
SDC Capture BYOD aligns with SDC’s growth strategy, emphasizing investment in technological advancements to drive the next generation of clinical solutions.
Faith Kolb, COO of SDC, suggested that they are thrilled to offer this transformative solution that aligns with the evolving needs of clinical trials and that its cost-efficiency and effectiveness differentiate it from competing technologies.
This breakthrough ePRO solution further enhances SDC’s reputation for delivering superior clinical trial services. By committing to experienced teams and taking a personalized approach, SDC empowers its partners to achieve optimal clinical outcomes.
Jon Napitupulu is Director of Media Relations at The Clinical Trial Vanguard. Jon, a computer data scientist, focuses on the latest clinical trial industry news and trends.
